21 CFR Part 341, Subpart C - Labeling
prev | next
- § 341.70 Labeling of OTC drug products containing ingredients that are used for treating concurrent symptoms (in either a single-ingredient or combination drug product).
- § 341.72 Labeling of antihistamine drug products.
- § 341.74 Labeling of antitussive drug products.
- § 341.76 Labeling of bronchodilator drug products.
- § 341.78 Labeling of expectorant drug products.
- § 341.80 Labeling of nasal decongestant drug products.
- § 341.85 Labeling of permitted combinations of active ingredients.
- § 341.90 Professional labeling.